Replimune Group, Inc. - Common Stock, par value $0.001 per share (REPL)

CUSIP: 76029N106

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
80,239,086
Total 13F shares
22,018,833
Share change
+3,357,062
Total reported value
$315,719,677
Price per share
$14.35
Number of holders
61
Value change
+$48,171,940
Number of buys
44
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 76029N106?
CUSIP 76029N106 identifies REPL - Replimune Group, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Replimune Group, Inc. - Common Stock, par value $0.001 per share (REPL) as of Q4 2019

As of 31 Dec 2019, Replimune Group, Inc. - Common Stock, par value $0.001 per share (REPL) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,018,833 shares. The largest 10 holders included Omega Fund Management, LLC, Bain Capital Life Sciences Investors, LLC, Redmile Group, LLC, BVF INC/IL, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, EMERALD ADVISERS, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and Artal Group S.A.. This page lists 61 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.